Latest News & Features
Pharma
A Netherlands court ruling marks the latest win as Novo Nordisk ramps up efforts to protect semaglutide from unapproved products, copycats and an increasingly competitive market. 6 August 2026
Careers
The 34-lawyer group prompts the launch of a Silicon Valley office and strengthens the firm’s technology, life sciences and global litigation capabilities. 6 August 2026
Regulation & Industry
From advising pioneering startups to championing women in the profession, Fran Salisbury of Mewburn Ellis has spent her career making innovation count. Here, she reflects on the challenges, opportunities and motivations that continue to drive her. 5 August 2026
Careers
Strategic addition marks the latest investment in the firm’s European platform as demand for cross-border patent expertise continues to grow. 5 August 2026
Careers
With more than 25 years’ experience, the ex-EIP partner specialises in technology and life sciences, particularly SEPs and FRAND in the UK and Europe. 5 August 2026
In-house counsel
A transatlantic firm with intellectual property at its heart—what’s not to like? The firm’s 30-year veteran tells WIPR why leading a recruitment drive is a “big responsibility” as the combined firm looks to out-scale the opposition. 4 August 2026
MedTech
The medical device maker says that a split appellate decision raises broader questions about trade secret law, jurisdiction and when the clock starts ticking on misappropriation claims. 3 August 2026
Careers
Appointment strengthens the firm’s expertise in US International Trade Commission proceedings and cross-border intellectual property disputes. 3 August 2026
Pharma
A director review has overturned a PTAB ruling, questioning why it diverged from an ITC decision based on the same patent claims, prior art and evidence. 31 July 2026
Careers
The ex-Greenberg Traurig shareholder will oversee the office’s 14,000-strong patent division, as the agency prepares for the departure of deputy director Coke Morgan Stewart. 31 July 2026